Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Matrices for tissue-engineered skin.

Dietmar W Hutmacher1, Wolfgang Vanscheidt

  • 1Division of Bioengineering, Faculty of Mechanical Engineering, Department of Orthopaedic Surgery, Faculty of Medicine, National University of Singapore, Singapore.

Drugs of Today (Barcelona, Spain : 1998)
|January 18, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Matrix type influences embedded patient-derived osteosarcoma organoid invasion and response to treatment.

Frontiers in pharmacology·2026
Same author

How microrobots should be translated: A clinical and value-centered readiness framework.

Bioengineering & translational medicine·2026
Same author

Water status of photocurable decellularised extracellular matrix hydrogels using DSC and NMR relaxometry.

Journal of materials chemistry. B·2026
Same author

Effect of Gamma Irradiation and Simulated Physiological Conditions on the Physicochemical Properties of a 3D-Printed βTCP Composite.

Polymers·2026
Same author

Photocrosslinkable lung dECM hydrogels promote stiffness-dependent lung cancer growth and chemoresistance.

Materials today. Bio·2026
Same author

In situ mechanostimulation of biohybrid millirobots for enhanced cell functionality and delivery.

Science advances·2026
Same journal

Monoclonal antibodies for treatment of osteoporosis.

Drugs of today (Barcelona, Spain : 1998)·2023
Same journal

Tebentafusp: a novel drug for the treatment of metastatic uveal melanoma.

Drugs of today (Barcelona, Spain : 1998)·2023
Same journal

Sugemalimab, a novel PD-L1 inhibitor for treatment of advanced or metastatic non-small cell lung cancer.

Drugs of today (Barcelona, Spain : 1998)·2023
Same journal

Secukinumab, ixekizumab, bimekizumab and brodalumab for psoriasis and psoriatic arthritis.

Drugs of today (Barcelona, Spain : 1998)·2023
Same journal

Mitapivat for sickle cell disease and thalassemia.

Drugs of today (Barcelona, Spain : 1998)·2023
Same journal

Cenegermin for the treatment of dry eye disease.

Drugs of today (Barcelona, Spain : 1998)·2023
See all related articles

Skin tissue engineering, utilizing scaffold/cell constructs, offers significant therapeutic benefits for wound regeneration. This approach holds the potential to enhance quality of life and reduce healthcare costs, despite ongoing research into optimal matrix and cell choices.

Area of Science:

  • Biomedical Engineering
  • Regenerative Medicine
  • Materials Science

Background:

  • Molecular and cell-based therapies are advancing rapidly in healthcare.
  • Tissue engineering is emerging as a key technology alongside genetic engineering.
  • Cost-effective healthcare demands innovations that improve quality of life and reduce expenditure.

Purpose of the Study:

  • To review the current state and future directions of matrices in skin tissue engineering.
  • To highlight the potential of scaffold/cell constructs for wound regeneration.
  • To discuss critical research and product strategy considerations.

Main Methods:

  • Review of existing literature on skin tissue engineering matrices.
  • Analysis of natural and synthetic polymer scaffolds.

Related Experiment Videos

  • Consideration of autogenic versus allogenic cell sources.

    • Main Results:

    • Skin tissue engineering constructs show promise for wound regeneration.
    • Scaffold/cell constructs represent a potentially cost-effective treatment strategy.
    • Key decisions regarding matrix materials and cell types require further resolution.

    Conclusions:

    • Skin tissue engineering offers significant therapeutic advantages over current treatments.
    • Further research is needed to optimize matrix and cell selection for clinical application.
    • This field is poised to provide substantial benefits in wound care and beyond.